S. Georgopoulos et al., TRANSMEMBRANE TNF IS SUFFICIENT TO INDUCE LOCALIZED TISSUE TOXICITY AND CHRONIC INFLAMMATORY ARTHRITIS IN TRANSGENIC MICE, Journal of inflammation, 46(2), 1996, pp. 86-97
TNF plays a pivotal role in the pathogenesis of a broad spectrum of in
fectious, inflammatory, and autoimmune diseases. In addition to the se
creted mature 17 kD form, TNF exists as a bioactive precursor 26 kD tr
ansmembrane protein. Transmembrane TNF signaling has been directly ass
ociated with specific immune mechanisms, including the contact-depende
nt lymphocyte and monocyte-mediated cell killing and the CD40 ligand-i
ndependent, T cell-mediated polyclonal B cell activation. In previous
studies, we have reported that mice expressing 3'-UTR modified human T
NF transgenes develop chronic inflammatory polyarthritis with a 100% p
henotypic penetrance and timed disease onset. In additional experiment
s, we have also shown that high-level expression of human TNF in lymph
oid cells of transgenic mice results in both local (thymic hypoplasia)
and systemic (ischaemia, tissue necrosis, and wasting) TNF-mediated p
athology. In this study we show that transgenic mice expressing a T ce
ll-targeted membrane-associated mutant human TNF alpha protein are dis
playing only local TNF-mediated pathologies, ranging from lymphoid tis
sue derangements to proliferative synovitis and chronic inflammatory a
rthritis. These results demonstrate that in vivo, at least part of the
pathogenic activities of TNF alpha may be assigned to the functioning
of its uncleaved membrane-associated form. (C) 1996 Wiley-Liss, Inc.